Several studies showed that the levels of the inflammatory proteins MCP-1 and NLK are altered in neurodegenerative diseases, such as PD and AD14–16,21 for MCP-1, and multiple sclerosis (MS) and HD for NLK20,22. This evidence concerns the gene NLK and myeloid sarcoma.